Rheum Manpower Needs - More Programs! (12.2.2022)
December 2, 2022
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com
Biologics in Lupus – Why, Who, and When? Sponsored by GSK US Medical Affairs
December 1, 2022
Leading experts from the SLE Educators’ Network discuss how biologic therapies may help address key unmet needs in lupus, while highlighting how clinicians can identify the most appropriate patients for biologic treatment.
Topic Podcasts - JAK_TYK2
November 20, 2022
ACR22 Year in Review Report
Deucravacitinib in PsA
JAK inhibitors in rheumatic diseases
JAK vs TNF inhibitor Infections in RA
New Treatments for SLE?
Prelude to a Meeting (ACR22) (11.11.2022)
Switching Between JAK Inhibiters in RA
Tapering Methotrexate with Biologics or JAK Inhibitors in RA
Tofacitinib and RA-ILD
Upadacitinib vs Adalimumab in PsA using RAPID3
Topic Podcasts - Lupus Part3
November 20, 2022
Addressing Sexual Health and STD Prevention in Lupus Patients
CAR-T Therapies in Antiphospholipid Antibody Syndrome
Copays Reduce Adherence to SLE Medications
Diffuse alveolar hemorrhage in antiphospholipid syndrome
Hydroxychloroquine Update from ACR22
Low-grade Proteinuria in Non Renal Lupus: Should We be Worried?
Photovoice: A New Visual Research Method in Lupus
Stop Ordering Repeat ANAs!
Timely Fetal Screening Important in Positive Anti-Ro Antibody Pregnancies
Life or Organ Threatening SLE: What To Do? Is There Anything New?
Topic Podcasts - Lupus Part2
November 20, 2022
ACR22 Daily Recap: Saturday Recap
New Treatments for SLE?
Topic Podcasts - Lupus Part1
November 20, 2022
A Novel Treatment Response Measurement Tool for Lupus
ACR22 Year in Review Report
Breakthrough COVID infection in SLE during Omicron era
Effect of voclosporin in class V lupus nephritis
Lupus, Sex and STDs
Poor Medication Adherence in SLE and How to Improve It
Prelude to a Meeting (ACR22) (11.11.2022)
Should You Repeat the ENA Panel?
Urinary Biomarkers in Lupus
Urine Proteomics in SLE with Dr. Michelle Petri
Topic Podcasts - PsA Part2
November 19, 2022
ACR 2022 Appraisal, Praise & Critique (11.18.2022)
Best of ACR Day Two in PSA
Efficacy and Safety Results from BE OPTIMAL in PsA
JAK inhibitors in rheumatic diseases
Oligoarticular PsA: FOREMOST Study
Opioid use in PsA and SpA
PET CT Imaging to Define Risk of Progression from PSO to PsA
PsA and SPA: Cyclers, Switchers, Who is the Winner?
Switch vs Cycle in PsA
Women vs. Men: Response to Treatment in Seronegative Arthritis
Topic Podcasts - PsA Part1
November 19, 2022
Best of PsA on Day 1
Can computers tell the difference between RA & PsA?
Deucravacitinib in PsA
Differences in Presentation and Outcomes of Early vs Late Onset PsA
Opioids and Health Care Utilization in PsA and AS
Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor
PsA Cycling or Switching MOAs
The Dietary Intervention in PsA (DIPSA) Study
Ultrasound in PsA
Upadacitinib vs Adalimumab in PsA using RAPID3
